Clinical trial
Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel
NCT01839968 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- January 31, 2014
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acquired platelet disorder